Hydrocephalus remains one of the most common conditions encountered in neurosurgery, traditionally managed by ventriculoperitoneal (VP) shunting. Despite its effectiveness, shunt dependency is associated with certain complications including infection, obstruction, and repeated revisions, leading to increased morbidity and healthcare burden.
Over the last 70 years, cerebrospinal fluid (CSF) shunting and more recently endoscopic third ventriculostomy (ETV) have been the mainstays of hydrocephalus treatment. In recent years, choroid plexus cauterization (CPC) has re-emerged as an additional treatment strategy.
In combination with ETV, CPC increases the chances of successfully treating some cases with hydrocephalus, than ETV alone.
Endoscopic Third Ventriculostomy (ETV) has emerged as an alternative physiological treatment by creating a bypass for cerebrospinal fluid (CSF) flow. However, its success is limited in infants and in other varieties of hydrocephalus. The addition of Choroid Plexus Cauterization (CPC), which reduces CSF production, has been shown to improve outcomes when combined with ETV, particularly in younger patients.
The idea is based on the principle that ablation of the predominant source of CSF secretion within the brain, choroid plexus (CP), reduces CSF production. In addition, CPC may reduce CSF pulsatility, an effect which may be potentiated when combined with ETV, which might reduce intraventricular pulsations by serving as a pulsation absorber. These effects, in combination, may tip the balance in favour of CSF absorption and negate the need for shunting in a proportion of patients.
The combined ETV-CPC approach, popularized by Benjamin Warf, has demonstrated promising results in reducing shunt dependence, especially in resource-limited settings. However, variability in success rates persists due to differences in patient selection, etiology, and surgical expertise.
This study aims at evaluation of the efficacy of combined ETV-CPC as a primary treatment modality for hydrocephalus and to identify predictors of surgical success and failure, thereby optimizing patient selection and improving outcomes.
Inclusion Criteria:
Exclusion Criteria:
Ebrahim.ahmed@aun.edu.eg
1. History: A complete medical history will be taken from the mother, including age when diagnosed, history of NICU admission, history suggestive of infection, other congenital anomalies or family history and any neurological symptoms. 2. Through physical examination: * General examination including blood pressure, heart rate, respiratory rate, temprature. * Neurological examination especially for GCS, anterior fontanelle, head circumference, cranial nerve affection and mental and physical growth. * Visual assessment. 3. Investigations * Radiology: CT brain and/or MRI brain with CSF flowmetry. * Laboratory investigations like CBC, PT, PC,INR, renal enzymes and preoperative fitness. 4. Treatment modatities: Surgical strategy; ETV in combined with thermal cauterization of visible choroid plexus.
Improving Infant Hydrocephalus Outcomes in Uganda
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Precision Surgery for Pediatric Hydrocephalus: VPS vs. ETV With ML-Guided Prediction
Role of Endoscopic Third Ventriculostomy Imanagement of Hydrocephalus in Pediatric Age Group; Clinical and Surgical Outcome
Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants
ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus
Study of Choroid Plexus Cauterization in Patients With Hydrocephalus
A Study Comparing Two Treatments for Infants With Hydrocephalus